Cargando…

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15–17) is the world-class conference co-sponsored by the American Society of Clinical Oncology, the American Society for Radiation Oncology, the American Gastroenterological Association Institute, and the Society of Surgica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aprile, Giuseppe, Leone, Francesco, Giampieri, Riccardo, Casagrande, Mariaelena, Marino, Donatella, Faloppi, Luca, Cascinu, Stefano, Fasola, Gianpiero, Scartozzi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447178/ https://www.ncbi.nlm.nih.gov/pubmed/26045669 http://dx.doi.org/10.2147/OTT.S82624

Ejemplares similares

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer
por: Giampieri, Riccardo, et al.
Publicado: (2015)

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
por: Bittoni, Alessandro, et al.
Publicado: (2015)

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management
por: Del Prete, Michela, et al.
Publicado: (2015)

The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment
por: D’Anzeo, Marco, et al.
Publicado: (2014)

Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach
por: Bittoni, Alessandro, et al.
Publicado: (2013)

Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab
por: Giampieri, Riccardo, et al.
Publicado: (2015)

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
por: Faloppi, Luca, et al.
Publicado: (2016)

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2012)

Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients
por: Giampieri, Riccardo, et al.
Publicado: (2013)

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2011)

HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series
por: Aprile, Giuseppe, et al.
Publicado: (2013)

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab
por: Scartozzi, Mario, et al.
Publicado: (2012)

Drug waste minimization as an effective strategy of cost-containment in Oncology
por: Fasola, Gianpiero, et al.
Publicado: (2014)

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management
por: Scartozzi, Mario, et al.
Publicado: (2012)

Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients
por: Scartozzi, Mario, et al.
Publicado: (2012)

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials
por: Aprile, Giuseppe, et al.
Publicado: (2015)

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma
por: Bianconi, Maristella, et al.
Publicado: (2016)

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients
por: Giampieri, Riccardo, et al.
Publicado: (2016)

2016 Gastrointestinal Cancers Symposium: update on pancreatic cancer
por: Russo, Suzanne, et al.
Publicado: (2016)

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy
por: Faloppi, Luca, et al.
Publicado: (2016)

BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
por: Maccaroni, Elena, et al.
Publicado: (2021)

Symposium on gastrointestinal and liver disease
Publicado: (1975)

Breast and gastrointestinal cancer updates from ASCO 2015
por: Dawood, Shaheenah
Publicado: (2015)

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
por: Faloppi, Luca, et al.
Publicado: (2014)

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer
por: Loupakis, Fotios, et al.
Publicado: (2016)

Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
por: Maccaroni, Elena, et al.
Publicado: (2015)

VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
por: Scartozzi, M, et al.
Publicado: (2013)

Iron deficiency in gastrointestinal oncology
por: Verraes, Kristof, et al.
Publicado: (2015)

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
por: Faloppi, Luca, et al.
Publicado: (2015)

Role of Machine Learning in Precision Oncology: Applications in Gastrointestinal Cancers
por: Tabari, Azadeh, et al.
Publicado: (2022)

Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer
por: Keller, Rachel B., et al.
Publicado: (2023)

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
por: Lisanti, Camilla, et al.
Publicado: (2022)

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
por: Fanotto, Valentina, et al.
Publicado: (2016)

Introduction to Symposium on “Gastrointestinal Manifestations of Diabetes Mellitus”
por: McCallum, Richard W.
Publicado: (1983)

Updates from Gastrointestinal ASCO 2015
por: Dawood, Shaheenah
Publicado: (2015)

Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study
por: Fasola, Gianpiero, et al.
Publicado: (2008)

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2018)

Oncological emergencies associated with gastrointestinal tumors
por: Prenen, Klaas, et al.
Publicado: (2015)

Scope of Artificial Intelligence in Gastrointestinal Oncology
por: Goyal, Hemant, et al.
Publicado: (2021)

Precision Oncology in Gastrointestinal Stromal Tumors
por: Mechahougui, Hiba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2djdl8rj7430den17s0nq79d7